The Morphine Market Size was valued at USD 24.48 billion in 2022 and is projected to reach USD 45.31 billion by 2030, growing at a compound annual growth rate (CAGR) of 8% during the forecast period from 2023 to 2030.
Dowaload free sample Report : https://www.snsinsider.com/sample-request/2597
Key Segments Covered in Morphine Market:
- By Application
- Pain Management
- Anesthesia
- Cough Suppression
- By Route of Administration
- Oral
- Injectable
- Others
- By Distribution Channel
- Hospitals
- Retail Pharmacies
- Online Pharmacies
Segment Analysis
- Pain Management accounted for the largest market share in 2022, driven by increasing demand for effective pain relief solutions.
- Hospitals were the leading distribution channel, owing to higher patient admissions and availability of skilled healthcare professionals for morphine administration.
Recent Developments
- In February 2023, Purdue Pharma launched an extended-release morphine tablet for chronic pain management.
- In April 2022, Mallinckrodt Pharmaceuticals received FDA approval for a new injectable morphine formulation for acute pain relief.
Market Dynamics
- Increasing Chronic Pain Cases: Rising prevalence of chronic pain conditions globally drives demand for morphine and related opioid medications.
- Expanding Use in Healthcare Settings: Widening application of morphine in pain management across hospitals, clinics, and home care settings supports market growth.
- Technological Advancements: Continuous development of extended-release formulations and novel delivery methods enhances treatment efficacy, boosting market expansion.
- Rising Geriatric Population: Growing elderly population prone to chronic pain conditions contributes to market growth.
Key Players
- Purdue Pharma L.P.
- Mallinckrodt Pharmaceuticals
- Endo Pharmaceuticals Inc.
- Janssen Pharmaceuticals Inc.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Boehringer Ingelheim International GmbH
Regional Analysis
- North America dominated the market in 2022, driven by high incidence of chronic pain disorders, advanced healthcare infrastructure, and substantial opioid prescriptions.
- Europe followed closely, supported by rising geriatric population and increasing surgical procedures requiring post-operative pain management.
Key Takeaways
- The Morphine Market growth is propelled by rising incidence of chronic pain conditions and advancements in opioid therapeutics.
- Technological innovations and new product launches by key players contribute significantly to market expansion.
- North America and Europe are prominent regions due to high healthcare spending, robust regulatory framework, and extensive opioid utilization.
Enquiry About Morphine Market Report: https://www.snsinsider.com/enquiry/2597
Table of Content
- Introduction
- Research Methodology
- Morphine Market Dynamics
- Impact Analysis (COVID-19, etc.)
- Value Chain Analysis
- Porter’s 5 Forces Model
- PEST Analysis
- Market Segmentation (Application, Route of Administration, Distribution Channel)
- Regional Analysis
- Company Profiles
- Competitive Landscape
- Use Cases and Best Practices
- Conclusion
Access Full Report: https://www.snsinsider.com/reports/morphine-market-2597
About SNS Insider SNS Insider provides authoritative insights into global consumer and market trends, leading innovation through advanced methodologies and data science.
Related Reports
Atrial Fibrillation Devices Market Share
Artificial Hip Joint Market Size
Atrial Fibrillation Devices Market Share
Contact Us Akash Anand – Head of Business Development & Strategy
info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Website: SNS Insider